Azelon Pharmaceuticals

company

About

Azelon Pharmaceuticals develops novel formulations for the treatment of osteoporosis.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$4.50M
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2000
Number Of Employee
1 - 10
Operating Status
Active

Azelon Pharmaceuticals, formerly Zelos Therapeutics, a West Conshohocken, PA-based company focused on the development of novel formulations for the treatment of osteoporosis.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$4.50M
Azelon Pharmaceuticals has raised a total of $4.50M in funding over 2 rounds. Their latest funding was raised on Oct 11, 2011 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 11, 2011 Series A $4.50M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Azelon Pharmaceuticals is funded by 1 investors. Covington Funds are the most recent investors.
Investor Name Lead Investor Funding Round
Covington Funds Series A